| Serial Number | 88811294 |
| Word Mark | GEMYSIS |
| Filing Date | Wednesday, February 26, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 18, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 22, 2020 |
| Goods and Services | Pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of immune disorders; pharmaceutical preparations for immunotherapy through genetically engineered cell therapy; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of cancer and tumors for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations, namely, kits for the treatment of immune disorders for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of cancer and tumors for medical or clinical purposes; cell therapy products, namely, genetically engineered cells and medical preparations for the treatment of immune disorders for medical or clinical purposes; biological and pharmaceutical preparations for the treatment of cancer and immune disorders using genetically engineered cells |
| Goods and Services | Business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of cancer and tumors; business services, namely, wholesale distributorship services in the field of cellular immunotherapies for the treatment of immune disorders; pharmaceutical sales promotion for others |
| Goods and Services | Pharmaceutical research and development; medical and scientific research and development of cellular immunotherapies for the treatment of cancer and tumors; medical and scientific research and development of cellular immunotherapies for the treatment of immune disorders; conducting clinical trials for others regarding pharmaceutical preparations and drugs in the field of immunotherapy and cell therapy; scientific and technological services, namely, research, analysis, and clinical trials for others in the field of cellular immunotherapy; providing medical and scientific research information in the field of cellular immunotherapies; compiling scientific and or clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of cell therapy, genetics, immunology, rare diseases, and oncology; licensing of technology in the fields of pharmaceuticals and gene therapy |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 7, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 7, 2020 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, March 7, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Gemysis Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Newtown, PA 18940 |
| Party Name | Gemysis Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Newtown, PA 18940 |
| Event Date | Event Description |
| Monday, March 18, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 18, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, August 9, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, August 8, 2023 | SOU EXTENSION 5 GRANTED |
| Monday, July 24, 2023 | SOU EXTENSION 5 FILED |
| Monday, July 24, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, March 9, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 8, 2023 | SOU EXTENSION 4 GRANTED |
| Thursday, February 16, 2023 | SOU EXTENSION 4 FILED |
| Friday, March 3, 2023 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, February 16, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 2, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Sunday, July 31, 2022 | SOU EXTENSION 3 GRANTED |
| Sunday, July 31, 2022 | SOU EXTENSION 3 FILED |
| Sunday, July 31, 2022 | SOU TEAS EXTENSION RECEIVED |
| Monday, April 25, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 25, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 25, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, February 17, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, February 15, 2022 | SOU EXTENSION 2 GRANTED |
| Tuesday, February 15, 2022 | SOU EXTENSION 2 FILED |
| Tuesday, February 15, 2022 | SOU TEAS EXTENSION RECEIVED |
| Friday, August 13, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 11, 2021 | SOU EXTENSION 1 GRANTED |
| Wednesday, August 11, 2021 | SOU EXTENSION 1 FILED |
| Wednesday, August 11, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 1, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, June 1, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, June 1, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, February 16, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, February 10, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 10, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 10, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, December 22, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 22, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 2, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, November 13, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, November 13, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Friday, November 13, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, November 13, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Friday, November 13, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, November 12, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 11, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 11, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 15, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, May 15, 2020 | NON-FINAL ACTION E-MAILED |
| Friday, May 15, 2020 | NON-FINAL ACTION WRITTEN |
| Friday, May 15, 2020 | ASSIGNED TO EXAMINER |
| Saturday, March 7, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 5, 2020 | NEW APPLICATION ENTERED |